In metabolic disorders, biomarkers of insulin sensitivity or lipid metabolism can classify patients according to specific disease mechanisms for guiding the choice of interventions, for example, antidiabetic drugs or lifestyle modifications [161]. The gene discussed is INS; the disease is Other metabolic disease.